/depts/,/depts/uwhealth/,/depts/uwhealth/pharmacy/,/depts/uwhealth/pharmacy/therapeutics-comittee/,

/depts/uwhealth/pharmacy/therapeutics-comittee/

201709256

page

100

UWHC,UWMF,

Departments & Programs,UW Health,Pharmacy

Pharmacy and Therapeutics Committee

Pharmacy and Therapeutics Committee - Departments & Programs, UW Health, Pharmacy

Focus

Pharmacy and Therapeutics Committee Organization Chart

Pharmacy and Therapeutics
Committee Organization Chart

Aim

UW Health Pharmacy and Therapeutics Committee Organizational Policy

Responsibilities

The UW Health Pharmacy and Therapeutics (P&T) Committee will pursue its aim throught the following activities:

  1. Formulary
    1. The P&T Committee shall maintain processes for all additions, deletions, modifications, and restrictions to the drug formulary that maximize safe, efficient, evidence-based, rational drug use.
    2. At a minimum, drug formulary evaluation criteria will include: indication for use, effectiveness, drug interactions, risks (potential for medication errors, abuse potential, sentinel events) and cost.
    3. Review the complete formulary list on an annual basis to ensure continued relevance and safety.
    4. Formulary medications are approved for all United States Food and Drug Administration-approved indications and for all uses listed in Centers for Medicare and Medicaid Services-approved compendia (e.g. American Hospital Formulary Service Drug Information) unless otherwise explicitly stated.
    5. The P&T Committee shall maintain a process for the selection, approval, and procurement of medications that are not on the formulary.
  2. Adverse Drug Events
    1. The P&T Committee shall ensure the establishment processes for the reporting of medication errors, adverse drug reactions, and drug incompatibilities with subsequent evaluation and recommendations for medication use system improvements and or formulary changes.
  3. Medication Safety
    1. The P&T Committee shall ensure the establishment of policies and procedures for the storage, ordering, handling, dispensing, and administration of medications that pose a heighted risk of causing significant harm or injury to patients or staff (e.g. high-alert/high-risk medications, hazardous medications, high-risk patient populations)
  4. Investigational Drugs
    1. The P&T Committee will ensure the establishment of policies and procedures for reviewing, approving, supervising and monitoring investigational medications.
  5. Drug Shortages
    1. The P&T Committee will ensurethe establishment of policies and procedures to address medication shortages and outages that include the following: 
      1. communicating with appropriate staff and prescribers
      2. developing approved substitution protocols
      3. educating appropriate licensed independent practitioners, health care professionals and staff about these protocols
      4. obtaining medication in the event of a disaster
  6. Medication Use Evaluation
    1. The P&T Committee will participate in quality assurance activities related to medication use structure, processes and outcomes and make recommendations for improvement when appropriate.
  7. Drug Recalls
    1. The P&T Committee will ensure that policies and processes exist to monitor drug recall or discontinuation notifications from the Food and Drug Administration and manufactures and retrieve those medications when recalled or discontinued for safety reasons.
  8. Guidelines, Policies, Procedures, Order Sets, Delegation Protocols
    1. Guidelines, Policies, Procedures, Order Sets, Delegation Protocols concerning the evaluation, selection and therapeutic use of medications used in the diagnosis, treatment and prevention of disease are formulated by the committee according to the following method:
      1. Identification of need
      2. Prioritization of tasks
      3. Conducting analyses
      4. Making recommendations to approving bodies
      5. Guiding implementation
      6. Maintaining all documents with updating as necessary
      7. Measuring outcomes of use
    2. The P&T Committee will ensure the availability of up to date medication information relating to drug interactions and information of drug therapy, side effects, toxicology, dosage, indications for use, and routes of administration.
  9. Medication Delivery Devices
    1. The P&T Committee will ensure that policies and procedure exist for the use of medication delivery devices
    2. The P&T Committee will provide guidance on the selection of medication delivery devices